AquaBounty Technologies, Inc.

As of May 15, 2025, AquaBounty Technologies, Inc. is considered overvalued with troubling financial metrics, including a price to book value of 0.18 and a return on equity of -104.55%, and has significantly underperformed the S&P 500, declining by 54.53% over the past year.

As of June 9, 2025, the trend has shifted to mildly bearish due to bearish signals from daily moving averages and weekly RSI, despite a mildly bullish MACD, with the stock underperforming the S&P 500 over the past one to three years.

As of March 2022, the management team of AquaBounty Technologies, Inc. includes Non-Executive Independent Chairman Richard Clothier, CEO Sylvia Wulf, and Non-Executive Directors Rick Sterling, Richard Huber, Christine St.Clare, and James Turk. They guide the company's strategic direction.

AquaBounty Technologies, Inc. focuses on the research and commercialization of antifreeze proteins to enhance aquaculture productivity. It is a micro-cap company with a market cap of $2.92 million and reported a net profit of $1 million in March 2025.

As of Jun 18, AquaBounty Technologies, Inc. has a market capitalization of 2.92 million, with net sales of 0.71 million and a net profit of -64.46 million over the latest four quarters. The company reported shareholder's funds of 15.84 million and total assets of 34.06 million as of Dec 24.